In this study, researchers evaluated patients who had incomplete cCRT or experienced progression during or within 42 days of receiving cCRT, with an aim of identifying risk factors for these outcomes.

Sofetabart mipitecan is an antibody-drug conjugate consisting of an Fc-silent, folate receptor alpha specific monoclonal antibody attached to an exatecan payload.

Investigators sought to determine the cost-effectiveness of home- versus clinic-based anal cancer screening for increasing uptake among sexual and gender minorities.

In treatment-naïve, unresectable HCC patients, nivolumab plus ipilimumab provides a sustained benefit compared to lenvatinib or sorafenib.

Survival rates for all cancers are increasing, but threats to federal funding and access to care jeopardize these advances.

Investigators sought to describe the patterns of post-progression outcome for patients with HR+/HER2- advanced breast cancer treated with endocrine therapy and a CDK4/6 inhibitor.

Investigators assessed whether anticoagulation and platelet aggregation inhibition could have antitumoral effects when used along side targeted therapies for patients with unresectable stage III-IV ...

Investigators evaluated the association between risk-reducing bilateral mastectomy and overall and breast cancer–specific mortality in female carriers of BRCA pathogenic variants.

Dr Andrew Howard, chairman and president of the Kidney Transplant Collaborative, told the Associated Press that the drop off in kidney transplants would have been larger if not for a small increase of ...

Investigators assessed the association between race, ethnicity and neighborhood-level SES with mortality among young adults with mCRC.

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been observed with aspirin.